BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

469 related articles for article (PubMed ID: 8591581)

  • 1. A method to estimate effects of amino acid substitutions in blood coagulation factor IX from hemophilia B patients.
    Furutani H
    Medinfo; 1995; 8 Pt 2():909. PubMed ID: 8591581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequence and structural properties of identical mutations with varying phenotypes in human coagulation factor IX.
    Chavali S; Sharma A; Tabassum R; Bharadwaj D
    Proteins; 2008 Oct; 73(1):63-71. PubMed ID: 18393396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular characterization of hemophilia B in North Indian families: identification of novel and recurrent molecular events in the factor IX gene.
    Mahajan A; Chavali S; Kabra M; Chowdhury MR; Bharadwaj D
    Haematologica; 2004 Dec; 89(12):1498-503. PubMed ID: 15590401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An interactive mutation database for human coagulation factor IX provides novel insights into the phenotypes and genetics of hemophilia B.
    Rallapalli PM; Kemball-Cook G; Tuddenham EG; Gomez K; Perkins SJ
    J Thromb Haemost; 2013 Jul; 11(7):1329-40. PubMed ID: 23617593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure and function of factor IX: defects in haemophilia B.
    McGraw RA; Davis LM; Lundblad RL; Stafford DW; Roberts HR
    Clin Haematol; 1985 Jun; 14(2):359-83. PubMed ID: 3899439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Point mutations in four hemophilia B patients from China.
    Wang NS; Chen SH; Thompson AR
    Thromb Haemost; 1990 Oct; 64(2):302-6. PubMed ID: 2270538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Missense mutations and evolutionary conservation of amino acids: evidence that many of the amino acids in factor IX function as "spacer" elements.
    Bottema CD; Ketterling RP; Ii S; Yoon HS; Phillips JA; Sommer SS
    Am J Hum Genet; 1991 Oct; 49(4):820-38. PubMed ID: 1680287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Double mutation, a 2-bp deletion and Val211Ile, in the blood coagulation factor IX gene of a patient with severe hemophilia B].
    Seita I; Shinozawa K; Otaki M; Fujita S; Suzuki T; Amano K; Inaba H; Fukutake K
    Rinsho Byori; 2009 May; 57(5):417-24. PubMed ID: 19522246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Molecular diagnosis of inherited coagulation disorders--sequence analysis of hemophilia B patients with anti-factor IX antibodies].
    Tanimoto M; Matsushita T; Takamatsu J; Saito H
    Rinsho Byori; 1990 Sep; 38(9):1041-6. PubMed ID: 2232265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The current feature of the study on human coagulation factor IX mutant].
    Yan JB
    Yi Chuan; 2005 Sep; 27(5):833-8. PubMed ID: 16257919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Methylation of the factor IX gene--a basic reason for the mutation causing hemophilia B].
    Mazin AL
    Mol Biol (Mosk); 1995; 29(1):71-90. PubMed ID: 7723765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular genotyping of the Italian cohort of patients with hemophilia B.
    Belvini D; Salviato R; Radossi P; Pierobon F; Mori P; Castaldo G; Tagariello G;
    Haematologica; 2005 May; 90(5):635-42. PubMed ID: 15921378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic basis and carrier detection of hemophilia B of Chinese origin.
    Lin SW; Shen MC
    Thromb Haemost; 1993 Mar; 69(3):247-52. PubMed ID: 8470048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factor IX Chongqing: a new mutation in the calcium-binding domain of factor IX resulting in severe hemophilia B.
    Wang NS; Zhang M; Thompson AR; Chen SH
    Thromb Haemost; 1990 Feb; 63(1):24-6. PubMed ID: 2339358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two mutations of the factor IX gene including a donor splice consensus deletion and a point mutation in a Dutch patient with severe hemophilia B.
    Poort SR; Briët E; Bertina RM; Reitsma PH
    Thromb Haemost; 1990 Nov; 64(3):379-84. PubMed ID: 2096489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nucleotide substitutions at the -6 position in the promoter region of the factor IX gene result in different severity of hemophilia B Leyden: consequences for genetic counseling.
    Vidaud D; Tartary M; Costa JM; Bahnak BR; Gispert-Sanchez S; Fressinaud E; Gazengel C; Meyer D; Goossens M; Lavergne JM
    Hum Genet; 1993 Apr; 91(3):241-4. PubMed ID: 8478007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factor IX gene analysis in 70 unrelated patients with haemophilia B: description of 13 new mutations.
    Attali O; Vinciguerra C; Trzeciak MC; Durin A; Pernod G; Gay V; Ménart C; Sobas F; Dechavanne M; Négrier C
    Thromb Haemost; 1999 Nov; 82(5):1437-42. PubMed ID: 10595634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three distinct point mutations in the factor IX gene of three Japanese CRM+ hemophilia B patients (factor IX BMNagoya 2, factor IX Nagoya 3 and 4).
    Hamaguchi M; Matsushita T; Tanimoto M; Takahashi I; Yamamoto K; Sugiura I; Takamatsu J; Ogata K; Kamiya T; Saito H
    Thromb Haemost; 1991 May; 65(5):514-20. PubMed ID: 1871712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemophilia B with mutations at glycine-48 of factor IX exhibited delayed activation by the factor VIIa-tissue factor complex.
    Wu PC; Hamaguchi N; Yu YS; Shen MC; Lin SW
    Thromb Haemost; 2000 Oct; 84(4):626-34. PubMed ID: 11057861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel missense mutation in the coagulation factor IX catalytic domain associated with severe haemophilia B--Factor IXDelhi.
    Mahajan A; Sharma A; Chavali S; Kabra M; Chowdhury MR; Srinivasan N; Bharadwaj D
    Haemophilia; 2004 Sep; 10(5):550-2. PubMed ID: 15357782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.